Floatz logo

Ddavp

Large-Artery Atherosclerosis (Embolus/Thrombosis)

Band TherapeuticsPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Large-Artery Atherosclerosis (Embolus/Thrombosis) cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
SIMVASTATIN
Northern California Institute of Research and Education
Phase 4BBB
Lipitor
Erasmus Medical Center
Phase 4BB
ADVICOR COMPONENT NIACIN
University of Washington
Phase 4BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Asan Medical Center
Phase 4BB

View all 49 →

Same molecule, other indications

Ddavp is also rated in:

hemophilia ADormant
BB
Indicative ·
66 / 100
View asset →
nocturnal enuresisDormant
BB
Indicative ·
65 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →